Urothelial tumours of upper urinary tract chemotherapy

Czech version

Authors: J. Katolická
Authors‘ workplace: Onkologicko-chirurgické oddělení FN u svaté Anny v Brně
Published in: Urol List 2012; 10(2): 38-39

Overview

Upper urinary tract carcinomas are very similar (from the biological point of view) to bladder carcinomas, therefore knowledge and algorithms applied in bladder cancer treatment may apply here as well. Combinations based on cisplatin are preferred in neoadjuvant chemotherapy settings in upper urinary cancer treatment. In metastatic upper urinary tract carcinoma the same chemotherapy protocols as in metastatic bladder cancer are used.

Key words:
nephroureterectomy, intraluminal treatment, cisplatin

Sources

1. Babjuk M, Dvořáček J, Melichar B et al. Onkourologie. Praha: Galen 2005.

2. Teramukai S, Nishiyama H, Matsui Y et al. Evaluation for surrogacy of end points by using data from observational studies: tumor downstaging for evaluating neoadjuvant chemotherapy in invasive bladder cancer. Clin Cancer Res 2006; 12(1): 139–143.

3. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists. Lancet 1999; 354(9178): 533–540.

4. Sherif A, Rintala E, Mestad O et al. Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer-Nordic cystectomy trial 2. Scand J Urol Nephrol 2002; 36(6): 419–425.

5. Grossman HB, Natale RB, Tangen CM et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003; 349(9): 859–866.

6. Malstrom PU, Rintala E, Wahlquist R et al. Five-year follow up of prospective trial of radical cystectomy and neoadjuvant chemotherapy: nordic cystectomy trial 1. The Nordic Cooperative Bladder Cancer Study Group. J Urol 1996; 155(6): 1903–1906.

7. Cortesi E. Neoadjuvant treatment for locally advanced bladder cancer: a randomized prospective clinical trial. American Society of Clinical Oncology Annual Meeting. Philadelphia 1995.

8. Vale CL. Meta-analysis Group MCTU, London, UK. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient dataadvanced bladder cancer (ABC)meta-analysis collaboration. Eur Urol 2005; 48(2): 202–205.

9. Vale CL, On behalf of Meta-analysis Group MCTU, London, UK. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol 2005; 482(2): 189–199.